Oral Pharmaceutical composition comprising 5 - azacytidine, wherein the composition is substantially 5-azacytidine in the stomach after Administration, useful for treating a disease associated with abnormal Cell Proliferation, such as myelodysplastic syndrome and Ovarian Cancer (Divisional Application 1170 - 09).

• 收藏
• 分享

专利权人:

CELGENE CORPORATION

发明人:

ETTER, JEFFREY B.,LAI, MEI,BACKSTROM, JAY THOMAS

申请号：

CL2013001097

公开号：

CL2013001097A1

申请日:

2013.04.22

申请国别(地区):

CL

年份:

2013

代理人:

摘要：

The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.USO DE 5-AZACITIDINA PARA EL TRATAMIENTO DE UNA ENFERMEDAD SELECCIONADA DE SÍNDROME MIELODISPLÁSICO, LEUCEMIA MIELÓGENA, CÁNCER PULMONAR DE CÉLULAS NO PEQUEÑAS Y CÁNCER DE OVARIO ENTRE OTROS (DIVISIONAL DE LA SOLICITUD 1170-09).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/